Literature DB >> 12631789

Increasing incidence of resistance to trimethoprim and ciprofloxacin in epidemic Salmonella typhimurium DT104 in England and Wales.

E.J. Threlfall1, L.R. Ward, B Rowe.   

Abstract

Salmonella typhimurium definitive phage type (DT) 104 (= DT104) with chromosomally-encoded resistance to ampicillin, chloramphenicol, streptomycin, sulphonamides, and tetracyclines (= R-type ACSSuT) has become increasingly common in humans in England and

Entities:  

Year:  1997        PMID： 12631789     DOI： 10.2807/esm.02.11.00187-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  17 in total

1.  Is it time to change fluoroquinolone breakpoints for Salmonella spp.?

Authors:  Frank Møller Aarestrup; Camilla Wiuff; Kåre Mølbak; E John Threlfall
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

2.  Pilot study to evaluate microarray hybridization as a tool for Salmonella enterica serovar Typhimurium strain differentiation.

Authors:  C Pelludat; R Prager; H Tschäpe; W Rabsch; J Schuchhardt; W-D Hardt
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Surveillance of multidrug-resistant strains of Salmonella enterica serotype Typhimurium in southern Italy in the years 1992-1997.

Authors:  A Nastasi; C Mammina
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

4.  Incidence of quinolone resistance over the period 1986 to 1998 in veterinary Salmonella isolates from Germany.

Authors:  B Malorny; A Schroeter; R Helmuth
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

5.  Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field.

Authors:  E Giraud; A Brisabois; J L Martel; E Chaslus-Dancla
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

6.  Molecular characterization of multidrug-resistant Salmonella enterica subsp. enterica serovar Typhimurium isolates from swine.

Authors:  Wondwossen Abebe Gebreyes; Craig Altier
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

7.  Genome scale reconstruction of a Salmonella metabolic model: comparison of similarity and differences with a commensal Escherichia coli strain.

Authors:  Manal AbuOun; Patrick F Suthers; Gareth I Jones; Ben R Carter; Mark P Saunders; Costas D Maranas; Martin J Woodward; Muna F Anjum
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

8.  Increasing incidence and comparison of nalidixic acid-resistant Salmonella enterica subsp. enterica serotype typhimurium isolates from humans and animals.

Authors:  C Heurtin-Le Corre; P Y Donnio; M Perrin; M F Travert; J L Avril
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

9.  Multidrug resistance in Salmonella enterica serotype Typhimurium from humans in France (1993 to 2003).

Authors:  François-Xavier Weill; Françoise Guesnier; Véronique Guibert; Mohammed Timinouni; Marie Demartin; Lucette Polomack; Patrick A D Grimont
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

Review 10.  Salmonella typhimurium DT104: a virulent and drug-resistant pathogen.

Authors:  C Poppe; N Smart; R Khakhria; W Johnson; J Spika; J Prescott
Journal:  Can Vet J       Date:  1998-09       Impact factor: 1.008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.